QoL · adults and children with cystic fibrosis and with at least one G551D CFTR mutation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Frequency of transfusion · participants with β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events Post‐operative bleeding · participants with β‐thalassaemia
It is very uncertain whether the intervention changes adverse events Post‐operative bleeding (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events Post‐operative atelectasis · participants with β‐thalassaemia
It is very uncertain whether the intervention changes adverse events Post‐operative atelectasis (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events Intra‐operative bleeding · participants with β‐thalassaemia
It is very uncertain whether the intervention changes adverse events Intra‐operative bleeding (very low certainty).
1 finding from 1 review
Intervention not reported
Quality of life · participants with β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Non‐serious adverse events · participants with β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Haeatological indices · participants with β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Duration of hospital stay · participants with β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serum ferritin · participants with β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in frequency of vaso‐occlusive painful crises (as measured by pain diary days with significant pain) · people with sickle cell disease
1 finding from 1 review
Length of hospital stay · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in dense red cells in sickle cell disease · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Effects of K‐Cl cotransport red cell K+ and Mg2+ content (RBC magnesium) mM/kg Hb · people with sickle cell disease
1 finding from 1 review
Adverse events: diarrhoea and headache · people with sickle cell disease
1 finding from 1 review
Adverse events: including serious adverse events, vaso‐occlusive crisis, gastrointestinal disorder, headache or migraine, upper respiratory tract infection, rash · people with sickle cell disease
1 finding from 1 review
HRQoL score (Child‐reported PedsQL generic scale) at 1 week · people with sickle cell disease
1 finding from 1 review
HRQoL score (Child‐reported PedsQL multidimensional fatigue scale) at 1 week · people with sickle cell disease
1 finding from 1 review
HRQoL score (Child‐reported PedsQL sickle cell disease module) at 1 week · people with sickle cell disease
1 finding from 1 review
Length of hospital stay · people with sickle cell disease
1 finding from 1 review